Recombinant Human CD229/SLAMF3 Protein
Beta LifeScience
SKU/CAT #: BLK-00020P-100UG

Human CD229 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human CD229/SLAMF3 Protein
Beta LifeScience
SKU/CAT #: BLK-00020P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CD229/SLAMF3 Protein is expressed from HEK293 with mFc (IgG1) tag at the C-terminus.It contains Lys364-Asp452. |
Purity | > 95% as determined by Tris-Bis PAGE;> 90% as determined by HPLC |
Accession | Q9HBG7 |
Target Symbol | CD229/SLAMF3 |
Species | Human |
Expression System | HEK293 |
Tag | C-mFc |
Expression Range | Lys364-Asp452 |
Mol. Weight | The protein has a predicted MW of 35.56 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result. |
Form | Liquid |
Formulation | Supplied as 0.22 um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | CD229 was strongly and homogeneously overexpressed on the PC of patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma, MM, and PC leukemia. CD229 was particularly overexpressed on those PC showing an abnormal phenotype such as expression of CD56. Most importantly, CD229 was also highly expressed on those cells in the patients' BM displaying the phenotype of chemotherapy-resistant and myeloma-propagating cells. |